Tirzepatide 10mg Lyophilized Powder - High Purity GLP-1/GIP Agonist for Research

Tirzepatide 10mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This white lyophilized powder has shown promising results in metabolic research, particularly in studies related to type 2 diabetes and weight management.

The tirzepatide 10mg formulation is produced under strict quality control measures to ensure consistent purity and performance in research applications. As a dual agonist, it demonstrates enhanced efficacy compared to single receptor agonists, making it valuable for scientific investigations into metabolic pathways.

Research indicates that tirzepatide 10mg may offer superior glycemic control and weight loss effects through its unique mechanism of action. The compound activates both GIP and GLP-1 receptors, which are involved in glucose metabolism and appetite regulation.

This product is supplied as a lyophilized powder to ensure stability and longevity. Proper storage in cool, dry conditions is recommended to maintain the integrity of the tirzepatide 10mg formulation. Researchers should reconstitute with appropriate sterile solutions as needed for experimental protocols.

Note: This product is for research use only, not for human consumption. Proper laboratory safety protocols should be followed when handling tirzepatide 10mg or any research compounds.